NasdaqCM - Nasdaq Real Time Price USD

Avenue Therapeutics, Inc. (ATXI)

Compare
1.8900
+0.0200
+(1.07%)
At close: January 24 at 4:00:02 PM EST
1.7899
-0.10
(-5.30%)
After hours: 7:55:45 PM EST

Insider Purchases Last 6 Months

SharesTransactions
Purchases 235,500 3
Sales 61 1
Net Shares Purchased (Sold) 235,439 4
Total Insider Shares Held 141.02k --
% Net Shares Purchased (Sold) -249.40% --

Net Institutional Purchases Prior Quarter to Latest Quarter

Shares
Net Shares Purchased (Sold) --
% Change in Institutional Shares Held --

Insider Transactions Reported - Last Two Years

InsiderTransactionTypeValueDate
HERSKOWITZ NEIL Director Sale at price 2.00 per share. Direct 46 Dec 2, 2024
KRANZLER JAY D Director Sale at price 2.24 per share. Direct 137 Nov 5, 2024
KRANZLER JAY D Director Purchase at price 2.40 - 2.50 per share. Direct 1,250 Sep 30, 2024
MACLEAN ALEXANDRA M.D. Chief Executive Officer Stock Award(Grant) at price 0.00 per share. Direct 0 Sep 23, 2024
JIN DAVID Chief Operating Officer Stock Award(Grant) at price 0.00 per share. Direct 0 Sep 23, 2024
FORTRESS BIOTECH, INC. Beneficial Owner of more than 10% of a Class of Security Stock Award(Grant) at price 0.00 per share. Direct 0 Apr 16, 2024
FORTRESS BIOTECH, INC. Beneficial Owner of more than 10% of a Class of Security Stock Award(Grant) at price 0.00 per share. Direct 0 Jan 2, 2024
DAVIDOW ROBERT L Beneficial Owner of more than 10% of a Class of Security Sale at price 0.14 - 0.15 per share. Indirect 86,560 Dec 11, 2023
ROSENWALD LINDSAY A Director Purchase at price 0.72 per share. Direct 251,046 Sep 8, 2023
FORTRESS BIOTECH, INC. Beneficial Owner of more than 10% of a Class of Security Purchase at price 0.72 per share. Direct 301,255 Sep 8, 2023
FORTRESS BIOTECH, INC. Beneficial Owner of more than 10% of a Class of Security Stock Award(Grant) at price 0.00 per share. Direct 0 Mar 31, 2023

Related Tickers